<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(6)</volume><submitter>Kricheldorff J</submitter><pubmed_abstract>High-frequency deep brain stimulation of the subthalamic nucleus is used to treat motor symptoms in patients with Parkinson's disease. There is evidence that low-frequency stimulation in the range of 4-10 Hz may improve cognitive functions. This study investigates whether low-frequency deep brain stimulation of the subthalamic nucleus in the beta band (20 Hz) frequency can improve response inhibition in patients with Parkinson's disease. In a double-blind crossover design, &lt;i>N&lt;/i> = 17 participants with Parkinson's disease performed four neuropsychological experiments, while on their usual dopaminergic medication, under no, standard high-frequency and 20 Hz beta low-frequency deep brain stimulation. The experiments consisted of a response selection task (response execution), a flanker tas</pubmed_abstract><journal>Brain communications</journal><pagination>fcaf474</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12690201</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>20 Hz beta stimulation of the subthalamic nucleus improves response inhibition in Parkinson's disease.</pubmed_title><pmcid>PMC12690201</pmcid><pubmed_authors>Sauer T</pubmed_authors><pubmed_authors>Kricheldorff J</pubmed_authors><pubmed_authors>Witt K</pubmed_authors></additional><is_claimable>false</is_claimable><name>20 Hz beta stimulation of the subthalamic nucleus improves response inhibition in Parkinson's disease.</name><description>High-frequency deep brain stimulation of the subthalamic nucleus is used to treat motor symptoms in patients with Parkinson's disease. There is evidence that low-frequency stimulation in the range of 4-10 Hz may improve cognitive functions. This study investigates whether low-frequency deep brain stimulation of the subthalamic nucleus in the beta band (20 Hz) frequency can improve response inhibition in patients with Parkinson's disease. In a double-blind crossover design, &lt;i>N&lt;/i> = 17 participants with Parkinson's disease performed four neuropsychological experiments, while on their usual dopaminergic medication, under no, standard high-frequency and 20 Hz beta low-frequency deep brain stimulation. The experiments consisted of a response selection task (response execution), a flanker tas</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-06T01:31:10.971Z</modification><creation>2026-05-24T03:11:14.824Z</creation></dates><accession>S-EPMC12690201</accession><cross_references><pubmed>41383649</pubmed><doi>10.1093/braincomms/fcaf474</doi></cross_references></HashMap>